Literature DB >> 16907916

Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease.

B Barceló1, J Pons, A Fuster, J Sauleda, A Noguera, J M Ferrer, A G N Agustí.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by an excessive inflammatory response to inhaled particles, mainly tobacco smoking. T lymphocytes are important regulatory cells that secrete several cytokines and participate actively in this inflammatory response. According to the pattern of cytokines secreted, the immune response is classified as cytotoxic or type 1 [interferon (IFN)-gamma-, interleukin (IL)-2-dependent] and humoral or type 2 (IL-4-, IL-5-, IL-10- and IL-13-dependent). This paper sought to compare the intracellular profile of cytokine expression determined by flow cytometry in T lymphocytes harvested from bronchoalveolar lavage (BAL) and peripheral blood in patients with COPD, smokers with normal lung function and never smokers. We found that BAL T lymphocytes from COPD patients had a higher percentage of positive stained cells for most of the cytokines analysed when compared to never smokers or smokers with normal lung function. Differences reached statistical significance for IL-4, IL-10 and IL-13, particularly in CD8(+) T cells. Furthermore, the expression of most of these cytokines was related inversely to the degree of airflow obstruction present suggesting local activation and/or selective homing of T lymphocytes to the lungs in COPD patients. These observations were not reproduced in circulating T lymphocytes. These results suggest that BAL T lymphocytes in patients with COPD produce more cytokines than in controls and tend to show a type 2 pattern of intracellular cytokine expression, particularly a Tc-2 profile. This is related inversely to the degree of airflow obstruction present.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907916      PMCID: PMC1809717          DOI: 10.1111/j.1365-2249.2006.03167.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

2.  The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage.

Authors:  S Mattoli; J Kleimberg; M A Stacey; A Bellini; G Sun; M Marini
Journal:  Biochem Biophys Res Commun       Date:  1997-10-09       Impact factor: 3.575

3.  Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells.

Authors:  J Zhu; S Majumdar; Y Qiu; T Ansari; A Oliva; J C Kips; R A Pauwels; V De Rose; P K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2001-12-15       Impact factor: 21.405

Review 4.  Bronchoalveolar lavage: performance, sampling procedure, processing and assessment.

Authors:  S I Rennard; R Aalbers; E Bleecker; H Klech; L Rosenwasser; D Olivieri; Y Sibille
Journal:  Eur Respir J Suppl       Date:  1998-03

5.  Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.

Authors:  S P Atamas; V V Yurovsky; R Wise; F M Wigley; C J Goter Robinson; P Henry; W J Alms; B White
Journal:  Arthritis Rheum       Date:  1999-06

6.  Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease.

Authors:  J Pons; J Sauleda; J M Ferrer; B Barceló; A Fuster; V Regueiro; M R Julià; A G N Agustí
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

7.  Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.

Authors:  J M Löfdahl; K Cederlund; L Nathell; A Eklund; C M Sköld
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

8.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

Authors:  T Zheng; Z Zhu; Z Wang; R J Homer; B Ma; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes.

Authors:  M Vukmanovic-Stejic; B Vyas; P Gorak-Stolinska; A Noble; D M Kemeny
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

10.  An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.

Authors:  Sandra Grumelli; David B Corry; Li-Zhen Song; Ling Song; Linda Green; Joseph Huh; Joan Hacken; Rafael Espada; Remzi Bag; Dorothy E Lewis; Farrah Kheradmand
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

View more
  40 in total

1.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

Authors:  Timothy W Shipley; Heather M Kling; Alison Morris; Sangita Patil; Jan Kristoff; Siobhan E Guyach; Jessica E Murphy; Xiuping Shao; Frank C Sciurba; Robert M Rogers; Thomas Richards; Paul Thompson; Ronald C Montelaro; Harvey O Coxson; James C Hogg; Karen A Norris
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Overexpression of dominant negative peroxisome proliferator-activated receptor-γ (PPARγ) in alveolar type II epithelial cells causes inflammation and T-cell suppression in the lung.

Authors:  Lingyan Wu; Guixue Wang; Peng Qu; Cong Yan; Hong Du
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  c-Jun N-terminal kinase and Akt signalling pathways regulating tumour necrosis factor-α-induced interleukin-32 expression in human lung fibroblasts: implications in airway inflammation.

Authors:  Dagen Li; Dapeng Chen; Xuemei Zhang; Hong Wang; Zixin Song; Wenchun Xu; Yujuan He; Yibing Yin; Ju Cao
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 4.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

Review 5.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

Review 6.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 7.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

8.  Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells.

Authors:  S Hirosako; E Goto; K Fujii; K Tsumori; N Hirata; S Tsumura; H Kamohara; H Kohrogi
Journal:  Clin Exp Immunol       Date:  2008-11-26       Impact factor: 4.330

9.  Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.

Authors:  S Saha; V Mistry; R Siva; D Parker; R May; P Bradding; I D Pavord; C E Brightling
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

10.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.